Overview

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
A 12 week study to investigate the safety and effectiveness of arformoterol given twice daily compared to placebo in subjects with COPD.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Formoterol Fumarate
Pharmaceutical Solutions
Salmeterol Xinafoate